1h Free Analyst Time
The enzyme-linked immunosorbent assay (ELISA) market is forecasted to grow by USD 843.9 million during 2023-2028, accelerating at a CAGR of 16.82% during the forecast period. The report on the enzyme-linked immunosorbent assay (ELISA) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing need for frequent diagnostic testing among aging population, rise in toxicology testing in food industry, and increase in chronic diseases.
The enzyme-linked immunosorbent assay (ELISA) market is segmented as below:
By Application
- Vaccine development
- Immunology
- Diagnostics
- Drug monitoring and pharmaceutical industry
- Others
By End-user
- Hospitals and diagnostic centers
- Research laboratories
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the enzyme-linked immunosorbent assay (ELISA) market covers the following areas:
- Enzyme-linked immunosorbent assay (ELISA) market sizing
- Enzyme-linked immunosorbent assay (ELISA) market forecast
- Enzyme-linked immunosorbent assay (ELISA) market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global enzyme-linked immunosorbent assay (ELISA) market: Abbott Laboratories, Abcam PLC, Agilent Technologies Inc., Amgen Inc., Avantor Inc., Becton Dickinson and Co., Bio RAD Laboratories Inc., bioMerieux SA, Cardinal Health Inc., Crux Biolabs Pty Ltd., Danaher Corp., Eppendorf SE, Illumina Inc., Lonza Group Ltd., Merck KGaA, Novo Nordisk AS, Perkin Elmer Inc., QIAGEN NV, Siemens Healthineers AG, and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing importance of promotional activities."
According to the report, one of the major drivers for this market is the growing need for frequent diagnostic testing among aging population.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Abcam plc
- Agilent Technologies Inc.
- Amgen Inc.
- Avantor Inc.
- Becton Dickinson and Co.
- Bio Rad Laboratories Inc.
- bioMerieux SA
- Cardinal Health Inc.
- Crux Biolabs Pty Ltd.
- Danaher Corp.
- Eppendorf SE
- Illumina Inc.
- Lonza Group Ltd.
- Merck KGaA
- Novo Nordisk AS
- Perkin Elmer Inc.
- QIAGEN NV
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
